Targeting the endocannabinoid system to correct GABA abnormalities in patients with Fragile-X syndrome
Targeting the endocannabinoid system to correct GABA abnormalities in patients with Fragile-X syndrome
批准号:
433726
负责人:
Lepage Jean-Francois
金额:
$38.73万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
未结题
起止时间:
2020-10-01 至 2025-10-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Fragile-X syndrome (FXS) is the primary hereditary cause of intellectual disability and the first monogenic cause of autism spectrum disorder. There is currently no cure for FXS, and the few therapeutic options available focus solely on the management of
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Prenatal Flame Retarndant Exposure on Brain Development: A multimodal neuroimanging study in a cohort of school aged children
-
批准号:354644
-
项目类别:Operating Grants
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Lepage Jean-Francois
-
依托单位:
Genetics and neurophysiology of social cognition in prepubertal individuals with Turner syndrome
-
批准号:224274
-
项目类别:Fellowship Programs
-
资助金额:$13.11万
-
财政年份:2011
-
负责人:Lepage Jean-Francois
-
依托单位:
海外基金